Figure 3From: Gastrointestinal delivery of propofol from fospropofol: its bioavailability and activity in rodents and human volunteersAnalgesic effect of orally administered fospropool in rat chronic constrictive injury model of neuropathic pain. Withdrawal latency measurements were taken starting 45–60 min post-dose. Fospropofol was effective in reducing hyperalgesia at doses of 75 and 100 mg/kg (a). This effect was not due to a non-selective sedative effect as latency on the non-ligated side did not change with fospropofol treatment (b). n = 10 rats per group. p < 0.05 vs vehicle noted as “*”. Data shown as mean ± SEM.Back to article page